Current status of diagnosis and treatment of IgG4-related sclerosing cholangitis
10.3969/j.issn.1001-5256.2016.10.047
- VernacularTitle:IgG4相关性硬化性胆管炎的诊断和治疗现状
- Author:
Dan YE
1
;
Guohua LI
Author Information
1. Department of Gastroenterology, The Fist Affiliated Hospital of Nanchang University, Nanchang 330006, China
- Publication Type:Research Article
- Keywords:
cholangitis, sclerosing;
diagnosis;
therapy;
review
- From:
Journal of Clinical Hepatology
2016;32(10):2021-2025
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, many reports on the diagnosis and treatment of IgG4-related sclerosing cholangitis have been published in China and foreign countries, but due to the small number of cases, there are few large-scale controlled clinical trials. Therefore, this article reviews the literature on the diagnosis and treatment of IgG4-related sclerosing cholangitis and points out that the diagnosis of IgG4-related sclerosing cholangitis needs complete clinical data and comprehensive pathological examinations, and its treatment relies on glucocorticoids and immunosuppressants.
